RADIOGARDASE
What it isFerric hexacyanoferrate binding thallium and caesium in the gut; radiocaesium and thallium poisoning.
Why this oneIt interrupts enterohepatic recirculation, cutting the biological half-life of caesium by about two-thirds.
What limits itIt works only on what re-enters the gut, so it does not remove what is already fixed in tissue. Constipation; blue stools.
Read the full label on DailyMed ↗
| FDA dosing | Population | Start | Target | Max |
|---|---|---|---|---|
| Internal contamination with radioactive cesium (137Cs) and/or thallium | Adults & adolescents | 3 g (6 capsules) TID (9 g/day) | ||
| Internal contamination with radioactive cesium (137Cs) and/or thallium | Pediatric 2–12y | 1 g (2 capsules) TID (3 g/day) |
Renal Undefined
Hepatic Not systemically bioavailable; may be less effective in hepatic impairment due to decreased biliary excretion of cesium/thallium
Pregnancy Category C; not absorbed from the GI tract, so fetal effects not expected — untreated cesium/thallium toxicity outweighs potential reproductive risk.
Lactation Excretion in milk unlikely (not absorbed), but women internally contaminated with cesium or thallium should not breastfeed.
NO BOXED WARNINGS
Principal riskIt works only on what re-enters the gut, so it does not remove what is already fixed in tissue
